Page 612 - Coronavirus Vaccine

Bharat Biotech's Covaxin safe, immunises for at least 3 months: Lancet

Probability of side effects from vaccine 10-12%, 6x lower than other shots

How Africa can save the world from a never-ending Covid-19 pandemic

If Africa is not vaccinated and remains a source of coronavirus mutations, the whole world will be at risk

India at forefront in fight against Covid-19 pandemic: IMF's Gita Gopinath

Gopinath praised India for playing a very important role during the crisis by manufacturing and shipping the Covid vaccines to several nations

Women report worse side-effects after receiving Covid-19 vaccine: Study

The news isn't all bad for women, though. Side effects are usually mild and short-lived.

Over 34K people vaccinated in Delhi against coronavirus on Tuesday

Over 34,000 beneficiaries received shots of the COVID-19 vaccine in the national capital on Tuesday, including 17,368 senior citizens, as per official data. In the 45-59 years age group, 2,833 beneficiaries received the jabs, a senior official said. On Monday, 35,738 people were administered the vaccine, the highest so far since the start of the exercise on January 16, according to official data. On Tuesday, a total of 34,239 beneficiaries got the jabs, the senior official said. Senior BJP leader J P Nadda tweeted that he received his first shot of the vaccine on Tuesday and shared pictures of him getting the jab. "Took my first dose of the indigenous Bharat Biotech's Covaxin. Gratitude to our hardworking scientists for the vaccine and salute to doctors' & paramedics' efforts in carrying out the largest vaccination drive of the world. Together, we will make India COVID-19 free," he tweeted. East Delhi Mayor Nirmal Jain too received the first shot on Tuesday and said, "The vaccine

Classification for Covid jab based on vulnerability to virus: Centre to HC

The Centre told the Delhi HC that classification of citizens for the purpose of COVID vaccination is based upon most rational and non-arbitrary criteria depending upon their vulnerability to the virus

J&J 'under stress' to meet EU second-quarter vaccine supply goal: Report

BRUSSELS (Reuters) - Johnson & Johnson has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its COVID-19 vaccine to the bloc in the second quarter of the year, an EU official told Reuters.

Coronavirus LIVE: Maharashtra reports 9,927 new cases in last 24 hours

The countrywide coronavirus vaccination drive was rolled out on January 16 and vaccination of the FLWs started from February 2. Stay tuned for Coronavirus live updates.

India needs 2.5 mn daily vaccinations to cover 30% population by Dec

Under 1 per cent of the population has been vaccinated so far

103-year-old Noida man takes coronavirus vaccine, feels 'fit and fine'

A 103-year-old Noida resident was administered the COVID-19 vaccine Tuesday, becoming the oldest person yet in Uttar Pradesh's Gautam Buddh Nagar district to have got inoculated

Russia to make Sputnik V vaccine in Italy; a first in European Union

Russia has signed a deal to produce its Sputnik V coronavirus vaccine in Italy, the first contract in the European Union, the Italian Russian Chamber of Commerce announced Tuesday.

Kerala records 2,316 fresh Covid-19 infections, 16 fatalities

The infection count is at 10,81,404

Covaxin demand, acceptability grows among Indians after efficacy results

A major boost to the vaccine's acceptability came after Prime Minister Narendra Modi received the first dose of the vaccine earlier this month

Russia to make Sputnik V vaccine in Italy, a first in European Union

Russia has signed a deal to produce its Sputnik V coronavirus vaccine in Italy

India's GDP to grow 12.6% in FY22, highest among G20 countries: OECD

OECD hikes 2021 global growth forecast to 5.6% from 4.2%; OECD doubles US growth forecast to 6.5% on stimulus

Pfizer vaccine neutralised UK, Brazil and South Africa variants in lab

While the research needs to be validated with real-world data, it offers another reason for optimism that the Covid vaccines are generally performing well against variants of the virus

Moderna, Pfizer less effective against S. Africa Covid variant: Study

The vaccines appear significantly less effective against the Covid variant that first emerged in South Africa, the study finds

Covaxin phase 2 data shows safety, induces immune response: Lancet Study

Covaxin is India's first indigenous vaccine against Covid-19

Delhi govt presents Rs 69,000-crore 'Deshbhakti Budget'; free Covid jabs

The Delhi government presented a Rs 69,000-crore budget themed on "patriotism" for financial year 2021-22

No vaccine shortage in Rajasthan, Union Health Ministry clarifies

The Union Health Ministry on Tuesday said the factual position is that there is no shortage of COVID-19 vaccine in the State at present